Platelet Aggregation Devices Market by Product (Systems, Reagents, Consumables, Accessories), Application (Research, Diagnostic, CVD, Orthopedic, Trauma), End User (Hospitals, Diagnostic Laboratories, Academia, Blood Banks) - Global Forecasts to 2020
The global platelet aggregation devices market is poised to reach a value of $342.4 Million by 2020, growing at a CAGR of 21.0% from 2015 to 2020. Factors such as rising incidences of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometers, and increasing number of industry-academia collaborations and clinical studies are fueling the growth of the global market. However, procedural limitations, unfavorable healthcare reforms in the U.S., and dearth of well trained and skilled professionals are some of the key factors restraining the growth of this market.
North America (particularly the U.S.) is poised to be the fastest growing region in global platelet aggregation devices market during the forecast period. North American region has become attractive destination for companies engaged in the development, manufacture, and distribution of platelet aggregation products. Factors such as growing number of surgical procedures, rising awareness among healthcare professionals (related to the benefits offered by platelet aggregation testing in disease diagnosis), large number of patients undergoing cardiovascular surgeries, and increasing prevalence of orthopedic, urological, and bleeding disorders are offering high-growth opportunities for players active in the North American platelet aggregation devices market.
As of 2014, F. Hoffmann La-Roche Ltd. (Switzerland) dominated the global platelet aggregation devices market. Over the past three years, the company adopted new product launches and strategic partnerships, collaborations, and alliances as its key business strategies to maintain its position in the market. The other key players in this market are Haemonetics Corporation (U.S.), Sysmex Corporation (Japan), Siemens AG (Germany), Accriva Diagnostics (U.S.), Helena Laboratories Corporation (U.S.), Bio/Data Corporation (U.S.), Tem Group (Switzerland), Sentinel CH. S.p.A. (Italy), and Aggredyne, Inc. (U.S.).
Want to explore hidden markets that can drive new revenue in Platelet Aggregation Devices Market?
This research report categorizes the platelet aggregation devices market into the following segments and subsegments:
Market, by Product
- Systems
- Reagents
- Consumables and Accessories
Market, by Application
- Research Applications
- Clinical Applications
- Cardiovascular Applications
- Orthopedic Applications
- Other Clinical Applications (Bleeding Disorders, Antiplatelet Therapy, and Trauma)
Market, by End User
- Standalone Hospitals
- Diagnostic Laboratories
- Research and Academic Institutes
- Other End Users (Blood Banks and Pharmaceutical & Biotechnology Companies)
Market, by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- Rest of the World (RoW)
The global platelet aggregation devices market is poised to reach ~$342.4 Million by 2020, growing at a CAGR of 21.0% from 2015 to 2020. Market growth can be attributed to factors such as rising incidence of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometers, and increasing number of industry-academia collaborations & clinical studies. However, factors such as procedural limitations, unfavorable healthcare reforms in the U.S., and dearth of well trained & skilled professionals are restraining the growth of this market. In addition, stringent regulatory policies and limited medical reimbursements are posing significant challenges for the growth of the market.
On the basis of product, the global platelet aggregation devices market is classified into three major segments, namely, instruments, reagents, and consumables & accessories. The Systems segment is expected to account for the largest share of the global market in 2015. This product segment is expected to grow at the highest CAGR in the next five years, owing to factors such as continuous technological advancements in the field of sensors and detectors, rising trend of automation of platelet aggregation testing procedures, growing adoption & market preference for automated instruments among diagnostic laboratories, and improved patient compliance offered by point-of-care testing analyzers as compared to conventional instruments.
On the basis of end user, the global platelet aggregation devices market is classified into standalone hospitals, diagnostic laboratories, research & academic institutes, and other end users (blood banks & pharmaceutical-biotechnology companies).Standalone hospitals segment is expected to account for the largest share of the global market in 2015. This segment is expected to grow at the highest CAGR in the next five years as well, owing to benefits offered by hospitals in conducting platelet aggregation testing procedure, large patient population base for target diseases (such as bleeding disorders, cardiovascular diseases, and arthritis), growing public-private investments for development and modernization of healthcare infrastructure, and increasing number of hospitals across developing countries.
Geographically, the platelet aggregation devices market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, the global market is expected to be dominated by North America. North American platelet aggregation devices market is also poised to grow at the highest CAGR owing to factors such as large patient population for target diseases (such as arthritis, leukemia, and hemophilia), strong presence of device manufacturers in the region, growing number of surgical procedures performed annually, growing awareness among healthcare professionals (related to the benefits offered by platelet aggregation testing in disease diagnosis), and availability of significant investments to support R&D programs that utilize platelet
New product launches and product developments are the key strategies adopted by major players to develop their positions in the global platelet aggregation devices market. Moreover, strategies such as acquisitions & divestments; partnerships, agreements, & collaborations; and geographic expansions were also adopted by a significant number of market players to strengthen their product portfolios and to expand their geographic presence in the global market. F. Hoffmann La-Roche Ltd. (Switzerland), Haemonetics Corporation (U.S.), Sysmex Corporation (Japan), Siemens AG (Germany), Accriva Diagnostics (U.S.), Helena Laboratories Corporation (U.S.), Bio/Data Corporation (U.S.), Tem Group (Switzerland), Sentinel CH. S.p.A. (Italy), and Aggredyne, Inc. (U.S.) are the key players operating in the global Platelet Aggregation Devices Market.
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Table of Contents
1 Introduction (Page No. - 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 19)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.4.1 Assumptions
3 Executive Summary (Page No. - 27)
3.1 Introduction
3.2 Current Market Scenario
3.3 Future Outlook
3.4 Conclusion
4 Premium Insights (Page No. - 31)
4.1 Global Platelet Aggregation Devices Market, 2015–2020
4.2 Global Platelet Aggregation Devices Market, By Region (2015–2020)
4.3 Platelet Aggregation Devices Market, By Product (2015)
4.4 Global Market, By Application (2015–2020)
4.5 Global Market, By End User (2015–2020)
5 Market Overview (Page No. - 36)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Key Market Drivers
5.3.1.1 Rising Incidence of Target Diseases
5.3.1.2 Rapid Growth in the Geriatric Population Across the Globe
5.3.1.3 Technological Advancements in Platelet Aggregometers
5.3.1.4 Increasing Number of Industry-Academia Collaborations and Clinical Studies
5.3.2 Key Market Restraints
5.3.2.1 Procedural Limitations
5.3.2.2 Unfavorable Healthcare Reforms in the U.S.
5.3.2.3 Dearth of Well-Trained, Skilled, and Experienced Professionals
5.3.3 Key Market Opportunities
5.3.3.1 Emerging Markets
5.3.3.2 Advent of Point-Of-Care & Miniaturized Platelet Aggregometers
5.3.4 Key Market Challenges
5.3.4.1 Stringent Regulatory Policies
5.3.4.2 Limited Medical Reimbursements
6 Platelet Aggregation Devices Market, By Product (Page No. - 48)
6.1 Introduction
6.2 Systems
6.3 Reagents
6.4 Consumables and Accessories
7 Platelet Aggregation Devices Market, By Application (Page No. - 53)
7.1 Introduction
7.2 Clinical Applications
7.2.1 Cardiovascular Applications
7.2.2 Orthopedic Applications
7.2.3 Other Clinical Applications
7.3 Research Applications
8 Platelet Aggregation Devices Market, By End User (Page No. - 62)
8.1 Introduction
8.2 Standalone Hospitals
8.3 Diagnostic Laboratories
8.4 Research and Academic Institutes
8.5 Other End Users
9 Platelet Aggregation Devices Market, By Region (Page No. - 70)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe (RoE)
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific (RoAPAC)
9.5 Rest of the World (RoW)
10 Competitive Landscape (Page No. - 102)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Scenario
10.4 Recent Developments
10.4.1 New Product Launches and Product Enhancements
10.4.2 Acquisitions and Divestments
10.4.3 Agreements, Partnerships, and Collaborations
10.4.4 Geographical Expansions
10.4.5 Other Developments
11 Company Profiles (Page No. - 111)
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 Introduction
11.1.1 Geographic Revenue Mix
11.1.2 Strategic Benchmarking
11.1.2.1 Product Development and Commercialization
11.2 F. Hoffman-La Roche Ltd.
11.3 Haemonetics Corporation
11.4 Sysmex Corporation
11.5 Siemens AG
11.6 Accriva Diagnostics
11.7 Helena Laboratories Corporation
11.8 Bio/Data Corporation
11.9 Sentinel Ch. S.P.A.
11.10 TEM Group
11.11 Aggredyne, Inc.
*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. - 130)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
List of Tables (71 Tables)
Table 1 Rise in Target Patient Population is Replicating Into Higher Market Demand for Platelet Aggregation Products
Table 2 Procedural Limitations Related to Platelet Aggregometry is Resulting in Its Subdued Adoption Among Healthcare Professionals
Table 3 Emerging Markets Offers Significant Growth Opportunities in Platelet Aggregation Devices Market
Table 4 Stringent Regulatory Framework is Negatively Affecting the Market Growth in the U.S.
Table 5 Global Platelet Aggregation Devices Market Size, By Product, 2013–2020 (USD Million)
Table 6 Platelet Aggregation Systems Market Size, By Region, 2013–2020 (USD Million)
Table 7 Platelet Aggregation Reagents Market Size, By Region, 2013–2020 (USD Million)
Table 8 Platelet Aggregation Consumables and Accessories Market Size, By Region, 2013–2020 (USD Million)
Table 9 Global Platelet Aggregation Devices Market Size, By Application, 2013–2020 (USD Million)
Table 10 Global Market Size for Clinical Applications, By Type, 2013–2020 (USD Million)
Table 11 Market Size for Clinical Applications, By Region, 2013–2020 (USD Million)
Table 12 Market Size for Cardiovascular Applications, By Region, 2013–2020 (USD Million)
Table 13 Platelet Aggregation Devices Market Size for Orthopedic Applications, By Region, 2013–2020 (USD Million)
Table 14 Market Size for Other Clinical Applications, By Region, 2013–2020 (USD Million)
Table 15 Market Size for Research Applications, By Region, 2013–2020 (USD Million)
Table 16 Global Platelet Aggregation Devices Market Size, By End User, 2013–2020 (USD Million)
Table 17 Platelet Aggregation Devices Market Size for Standalone Hospitals, By Region, 2013-2020 (USD Million)
Table 18 Market Size for Diagnostic Laboratories, By Region, 2013–2020 (USD Million)
Table 19 Market Size for Research and Academic Institutes, By Region, 2013–2020 (USD Million)
Table 20 Platelet Aggregation Devices Market Size for Other End Users, By Region, 2013–2020 (USD Million)
Table 21 Platelet Aggregation Devices Market Size, By Region, 2013–2020 (USD Million)
Table 22 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 23 North America: Market Size, By Product, 2013–2020 (USD Million)
Table 24 North America: Market Size, By Application, 2013–2020 (USD Million)
Table 25 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 26 U.S.: Market Size, By Product, 2013–2020 (USD Million)
Table 27 U.S.: Market Size, By Application, 2013–2020 (USD Million)
Table 28 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 29 Canada: Market Size, By Product, 2013–2020 (USD Million)
Table 30 Canada: Market Size, By Application, 2013–2020 (USD Million)
Table 31 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 32 Europe: Market Size, By Country, 2013–2020 (USD Million)
Table 33 Europe: Market Size, By Product, 2013–2020 (USD Million)
Table 34 Europe: Platelet Aggregation Devices Market Size, By Application, 2013–2020 (USD Million)
Table 35 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 36 Germany: Market Size, By Product, 2013–2020 (USD Million)
Table 37 Germany: Market Size, By Application, 2013–2020 (USD Million)
Table 38 Germany: Market Size, By End User, 2013–2020 (USD Million)
Table 39 U.K.: Market Size, By Product, 2013–2020 (USD Million)
Table 40 U.K.: Market Size, By Application, 2013–2020 (USD Million)
Table 41 U.K.: Market Size, By End User, 2013–2020 (USD Million)
Table 42 France: Market Size, By Product, 2013–2020 (USD Million)
Table 43 France: Market Size, By Application, 2013–2020 (USD Million)
Table 44 France: Market Size, By End User, 2013–2020 (USD Million)
Table 45 RoE: Platelet Aggregation Devices Market Size, By Product, 2013–2020 (USD Million)
Table 46 RoE: Market Size, By Application, 2013–2020 (USD Million)
Table 47 RoE: Market Size, By End User, 2013–2020 (USD Million)
Table 48 Asia-Pacific: Market Size, By Country, 2013–2020 (USD Million)
Table 49 Asia-Pacific: Market Size, By Product, 2013–2020 (USD Million)
Table 50 Asia-Pacific: Market Size, By Application, 2013–2020 (USD Million)
Table 51 Asia-Pacific: Market Size, By End User, 2013–2020 (USD Million)
Table 52 Japan: Market Size, By Product, 2013–2020 (USD Million)
Table 53 Japan: Market Size, By Application, 2013–2020 (USD Million)
Table 54 Japan: Market Size, By End User, 2013–2020 (USD Million)
Table 55 China: Market Size, By Product, 2013–2020 (USD Million)
Table 56 China: Market Size, By Application, 2013–2020 (USD Million)
Table 57 China: Market Size, By End User, 2013–2020 (USD Million)
Table 58 India: Market Size, By Product, 2013–2020 (USD Million)
Table 59 India: Market Size, By Application, 2013–2020 (USD Million)
Table 60 India: Market Size, By End User, 2013–2020 (USD Million)
Table 61 RoAPAC: Market Size, By Product, 2013–2020 (USD Million)
Table 62 RoAPAC: Market Size, By Application, 2013–2020 (USD Million)
Table 63 RoAPAC: Market Size, By End User, 2013–2020 (USD Million)
Table 64 RoW: Market Size, By Product, 2013–2020 (USD Million)
Table 65 RoW: Market Size, By Application, 2013–2020 (USD Million)
Table 66 RoW: Market Size, By End User, 2013–2020 (USD Million)
Table 67 New Product Launches and Product Enhancements, 2012–2015
Table 68 Acquisitions and Divestments, 2012–2015
Table 69 Agreements, Partnerships, and Collaborations, 2012–2015
Table 70 Geographical Expansions, 2012–2015
Table 71 Other Developments, 2012–2015
List of Figures (40 Figures)
Figure 1 Research Design
Figure 2 Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Data Triangulation
Figure 5 Assumptions of the Research Study
Figure 6 Market Share: Key Market Players, 2014
Figure 7 Future Trends: Platelet Aggregation Devices Market Size, By Product Type (2015–2020)
Figure 8 Future Trends: Platelet Aggregation Devices Market Size, By Application (2015–2020)
Figure 9 Future Trends: Platelet Aggregation Devices Market Share, By Region (2015–2020)
Figure 10 Attractive Market Opportunities in the Platelet Aggregation Devices Market
Figure 11 China, U.S., & India to Lead the Platelet Aggregation Devices Market During the Forecast Period
Figure 12 North America is Expected to Command the Largest Share of the Platelet Aggregation Products Market in 2015
Figure 13 China to Lead the Market for Platlet Aggregation Device Applications During the Forecast Period
Figure 14 Standalone Hospitals to Be the Key End-User Segment Across All the Key Regions for Platelet Aggregation Products
Figure 15 Key Factors Impacting Growth of the Platelet Aggregation Devices Market During 2015–2020
Figure 16 Increasing Proportion of Geriatric Individuals in the Total Population (2012 vs 2020)
Figure 17 Global Trend in the Government Healthcare Expenditure: Developed vs Developing Nations (2010–2012)
Figure 18 Platelet Aggregation Systems to Grow the Fastest Among All Products Categories During 2015 to 2020
Figure 19 Market is Expected to Witness Higher Growth for Clinical Applications Segment During the Forecast Period
Figure 20 Growing Geriatric Population is Expected to Fuel the Market Demand During the Forecast Period
Figure 21 Platelet Aggregation Research Applications Market in North America is Poised to Grow at the Highest CAGR During 2015-2020
Figure 22 Standalone Hospitals to Witness Highest Growth Among All End Users (2015-2020)
Figure 23 Rising Healthcare Expenditure Across the Globe to Stimulate the Market Demand of Platelet Aggregation Testing Products (2010-2012)
Figure 24 Large Number of Ongoing Clinical Trials is Propelling the Demand for Platelet Aggregation Testing Products By Pharma & Biotech Companies (2015)
Figure 25 North America to Lead the Platelet Aggregation Devices Market Among Key Regions During 2015–2020
Figure 26 The North American Platelet Aggregation Devices Market is Mainly Driven By High Incidences of Target Diseases in This Region
Figure 27 Platelet Aggregation Systems to Contribute the Maximum to the Platelet Aggregation Products Market Growth in the U.S. During the Forecast Period
Figure 28 European Market Snapshot: Germany is Expected to Command the Largest Market Share in 2015
Figure 29 Clinical Applications to Hold the Larger Market Share in the Platelet Aggregation Devices Applications Market in the U.K. (2015–2020)
Figure 30 Asia-Pacific Market Snapshot: China is Expected to Be the Fastest-Growing Regional Segment in APAC (2015–2020)
Figure 31 Standalone Hospitals Segment is Projected to Be the Fastest-Growing End-User Segment in China (2015–2020)
Figure 32 Leading Market Players Adopted Pipeline Development & Product Enhancement as Their Key Growth Strategy During 2012 to 2015
Figure 33 Global Market Share, By Key Player, 2014**
Figure 34 Continuous Product Development & Commercialization is Stimulating Market Competition Among Key Players
Figure 35 Geographic Revenue Mix of the Top Four Players (2014)*
Figure 36 Strategic Benchmarking: Leading Companies Focus on Product Commercialization to Strengthen Their Market Position
Figure 37 F. Hoffman-La Roche Ltd.: Company Snapshot
Figure 38 Haemonetics Corporation: Company Snapshot
Figure 39 Sysmex Corporation: Company Snapshot
Figure 40 Siemens AG: Company Snapshot
Generating Response ...
Growth opportunities and latent adjacency in Platelet Aggregation Devices Market